RN7SL382P

Across TCGA pan-cancer cohorts, RN7SL382P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL382P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL382P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL382P is over-expressed in tumor, although a few such as COAD and BRCA show the opposite, repressed pattern.

COAD, BRCA, and KIRP are the cancer types where RN7SL382P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL382P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	III,IV	−0.160	.018	4	view →
BRCA	All	III,IV	−0.222	.014	2	view →
KIRP	All	III,IV	+0.152	.016	2	view →
LUSC	All	All	−0.100	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL382P–COAD

Open the COAD breakdown →